Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Psoriatic arthritis
Apr 19, 2018
Four Canadian provinces add ErelziTM (etanercept) to provincial drug plans for the treatment of multiple inflammatory diseases
Apr 17, 2018
National Psoriasis Foundation Elects New Leaders to Board of Directors
Apr 10, 2018
Pfizer's Xeljanz Barrels into Psoriatic Arthritis, Leaving Lilly's Recently Launched Taltz in its Wake, According to a Recently Published Study from Spherix Global Insights
Apr 09, 2018
Upadacitinib Meets All Primary and Ranked Secondary Endpoints Including Superiority Versus Adalimumab in Phase 3 Study in Rheumatoid Arthritis
Mar 21, 2018
Sun Pharma Announces U.S. FDA Approval of ILUMYA(TM) (tildrakizumab-asmn) for the Treatment of Moderate-to-Severe Plaque Psoriasis
Mar 21, 2018
USRM Demonstrates 99% Reduction in Severity of Psoriasis Utilizing Autologous Stem Cells
Mar 13, 2018
Escalier Biosciences Raises $19 Million to Develop its Topical and Systemic RORgt Therapies for Psoriasis and other Autoimmune Diseases
Mar 05, 2018
Promising New Findings on Using Biologic Drugs Before and During Pregnancy
Mar 01, 2018
New Mexico Passes Step Therapy Reform Legislation
Feb 19, 2018
AAD 2018: Treatment with Lilly's Taltz® (ixekizumab) Resulted in Improvement in Impact of Genital Psoriasis on Sexual Activity
Feb 17, 2018
AbbVie Presents New Positive Late-Breaking Data from Two Phase 3 Psoriasis Trials of Risankizumab at the 2018 American Academy of Dermatology Annual Meeting
Feb 16, 2018
Novartis new data show Cosentyx® improved quality of life over 5 years in two thirds of patients with moderate to severe plaque psoriasis
Feb 16, 2018
New TREMFYA® (guselkumab) Data Demonstrates Long-Term Skin Clearance In Patients With Moderate To Severe Plaque Psoriasis
Feb 14, 2018
Lilly to Showcase New Data for Taltz® (ixekizumab) and Other Products Across Immunology Pipeline at AAD Annual Meeting
Feb 08, 2018
Novartis receives FDA approval for Cosentyx® label update to include moderate to severe scalp psoriasis
Jan 10, 2018
JAK Inhibitors Expected to Introduce Fierce Competition to Treatment Paradigms Across a Wide Range of Autoimmune Indications, Including Psoriatic Arthritis, Atopic Dermatitis, Ulcerative Colitis, and Lupus
Dec 11, 2017
Corrona® Psoriasis Registry Expands to Canada; Enrolls First Patient
Dec 04, 2017
Eli Lilly's Taltz Now Approved for Psoriatic Arthritis, Bringing Key Competition for Rival IL-17 Inhibitor, Novartis' Cosentyx
Dec 01, 2017
Lilly's Taltz® (ixekizumab) Receives U.S. FDA Approval for the Treatment of Active Psoriatic Arthritis
Nov 16, 2017
Global Psoriatic Arthritis Epidemiology and Patient Flow Analysis - 2017
‹‹
Page 5
››
Latest News
Apr 25, 2024
Bureau Veritas: Strong Start to the Year; 2024 Outlook Confirmed
Apr 25, 2024
Luxury Apartments in Double Bay, Australia, Built for Durability with Penetron Technology
Apr 25, 2024
Wright Electric Announces First Steps of Electric Propulsion Testing
Apr 25, 2024
Asahi Kasei to Construct a Lithium-ion Battery Separator Plant in Canada
Apr 25, 2024
Getech Engaged by East Star Resources to Locate Porphyry Copper in Kazakhstan
Apr 25, 2024
Helix Reports First Quarter 2024 Results
Apr 25, 2024
Mativ Announces Appointment of New Chair of its Board of Directors
Apr 25, 2024
Leading Industry Publication: Black & Veatch Remains Among Global Critical Infrastructure Leaders as...
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events